Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2004;63:1197-1204; doi:10.1136/ard.2003.011163
Copyright © 2004 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2004;63:1197-1204
© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism

EXTENDED REPORT

EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1ß in synovial fibroblasts

R Largo, I Díez-Ortego, O Sanchez-Pernaute, M J López-Armada, M A Alvarez-Soria, J Egido, G Herrero-Beaumont

Bone and Joint Research Unit, Fundación Jiménez Díaz, Autonoma University, Madrid, Spain

Correspondence to:
Correspondence to:
Dr G Herrero-Beaumont
Rheumatology Department, Fundación Jiménez Díaz, Avenida Reyes Católicos 2, 28040 Madrid, Spain, gherrero{at}fjd.es

Background: Besides its proinflammatory properties, prostaglandin E2 (PGE2) acts as a regulator of the expression of inducible genes. Inhibition of PGE2 synthesis might thus result in a paradoxical deleterious effect on inflammation.

Objective: To examine the effect of PGE2 on monocyte chemoattractant protein-1 (MCP-1) expression in cultured synovial fibroblasts (SF) stimulated with interleukin (IL)1ß.

Methods: MCP-1 expression was assessed in SF stimulated with IL1ß in the presence of PGE2 or different NSAIDs by RT-PCR or northern blot and immunocytochemistry. Expression of cyclo-oxygenase (COX) isoforms was studied by western blot techniques. The role of PGE2 receptors (EP) in PGE2 action was assessed employing EP receptor subtype-specific agonists.

Results: PGE2 significantly inhibited IL1ß induced MCP-1 expression in SF in a dose dependent manner. IL1ß increased COX-2 and did not alter COX-1 synthesis in SF. 11-Deoxy-PGE1, an EP2/EP4 agonist, reproduced PGE2 action on MCP-1 expression. Butaprost, a selective EP2 agonist, was less potent than PGE2. Sulprostone, an EP1/EP3 agonist, had no effect on IL1ß induced MCP-1 expression. Inhibition of endogenous PGE2 synthesis by NSAIDs further enhanced MCP-1 mRNA expression in IL1ß stimulated SF, an effect prevented by addition of exogenous PGE2.

Conclusion: Activation of EP2/EP4 receptors down regulates the expression of MCP-1 in IL1ß stimulated SF, while PGE2 pharmacological inhibition cuts off this signalling pathway and results in a superinduction of MCP-1 expression. The data suggest that NSAIDs may intercept a natural regulatory circuit controlling the magnitude of inflammation, which questions their continuous administration in inflammatory joint diseases.

Abbreviations: AC, adenylate cyclase; cAMP, cyclic adenosine monophosphate; COX, cyclo-oxygenase; DCF, diclofenac; EMSA, electrophoretic mobility shift assay; GAPDH, glyceraldehyde-3'-phosphate dehydrogenase; IL, interleukin; MCP-1, monocyte chemoattractant peptide-1; MXC, meloxicam; NSAIDs, non-steroidal anti-inflammatory drugs; PGE2, prostaglandin E2; RT-PCR, reverse transcription-polymerase chain reaction; SF, synovial fibroblasts

Keywords: EP2/EP4 receptors; monocyte chemoattractant protein-1; prostaglandin E2; synovial cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Kunisch, E., Jansen, A., Kojima, F., Loffler, I., Kapoor, M., Kawai, S., Rubio, I., Crofford, L. J., Kinne, R. W. (2009). Prostaglandin E2 Differentially Modulates Proinflammatory/Prodestructive Effects of TNF-{alpha} on Synovial Fibroblasts via Specific E Prostanoid Receptors/cAMP. J. Immunol. 183: 1328-1336 [Abstract] [Full Text]  
  • Molloy, E S, Morgan, M P, Doherty, G A, McDonnell, B, O'Byrne, J, Fitzgerald, D J, McCarthy, G M (2008). Mechanism of basic calcium phosphate crystal-stimulated matrix metalloproteinase-13 expression by osteoarthritic synovial fibroblasts: inhibition by prostaglandin E2. Ann Rheum Dis 67: 1773-1779 [Abstract] [Full Text]  
  • Alvarez-Soria, M. A., Herrero-Beaumont, G., Sanchez-Pernaute, O., Bellido, M., Largo, R. (2008). Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes. Rheumatology (Oxford) 47: 627-633 [Abstract] [Full Text]  
  • Minami, M., Shimizu, K., Okamoto, Y., Folco, E., Ilasaca, M.-L., Feinberg, M. W., Aikawa, M., Libby, P. (2008). Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-{kappa}B1 and Attenuates Macrophage Activation. J. Biol. Chem. 283: 9692-9703 [Abstract] [Full Text]  
  • Alvarez-Soria, M A, Largo, R, Santillana, J, Sanchez-Pernaute, O, Calvo, E, Hernandez, M, Egido, J, Herrero-Beaumont, G (2006). Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis 65: 998-1005 [Abstract] [Full Text]  
  • Nakayama, T., Mutsuga, N., Yao, L., Tosato, G. (2006). Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells. J. Leukoc. Biol. 79: 95-104 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs